Effect of Gastric Bubble as a Weight Reduction Device: A Controlled, Crossover Study

Meshkinpour, Hooshang; Hsu, D. T.; Farivar, Sirus

doi:10.1016/s0016-5085(88)80002-7

Cited by 72 publications

(35 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Extensive clinical experience has shown that the complication rate is very low. 5,6,8,9,[15][16][17] In the present study, BIB placement was safe and feasible. In all cases it was positioned after sedation only.…”

Section: -15supporting

confidence: 48%

“…10,11 Several researchers, over the years, have used different types of balloons as they were thought to be promising as less invasive than surgery for the treatment of morbid obesity. [12][13][14][15] At the end of the 1990s several prospective and controlled studies have reported that Ballobes or Garren-Edwards gastric bubbles had no significant effects as adjuvant device for weight reduction in morbidly obese patients. [12][13][14][15] Reasons for this were considered the small volume of the balloon (220 ml for GarrenEdwards and 400 ml for Ballobes), the air filling with no weight effect on the stomach wall, and the cylinder-like shape of these devices.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

BioEnterics® Intragastric Balloon (BIB®): a short-term, double-blind, randomised, controlled, crossover study on weight reduction in morbidly obese patients

et al. 2005

View full text Add to dashboard Cite

Background: The BioEnterics s Intragastric Balloon (BIB s ) System in association with restricted diet has been used for the shortterm treatment of morbid obesity. Aim of this study was to evaluate the real, short term, efficacy of the BIB for weight reduction in morbidly obese patients by using a prospective, double-blind, randomised, sham-controlled, crossover study. Methods: Patients were recruited from January 2003 to December 2003. After selection, they were randomly allocated into two groups: BIB followed by sham procedure after 3 months (Group A), and sham procedure followed by BIB after 3 months (Group B). All endoscopic procedures were performed under unconscious intravenous sedation. The BioEnterics Intragastric Balloon (Inamed Health; Santa Barbara, CA, USA) was filled by using saline (500 ml) and methylene blue (10 ml). Patients were discharged with omeprazole therapy and diet (1000 kcal). Patients were followed up weekly by a physician blinded to randomisation. In both groups mortality, complications, BMI, BMI reduction and %EWL were considered. Data were expressed as mean7s.d., except as otherwise indicated. Statistical analysis was performed by means of Student's t-test, Fisher's exact test or w 2 with Yates correction; Po0.05 was considered significant. Results: A total of 32 patients were selected and entered the study (8M/24F; mean age: 36.275.6 years, range 25-50 years; mean BMI 43.771.5 kg/m 2 , range 40-45 kg/m 2 ; mean %EW: 43.1713.1, range: 35-65). All patients completed the study. Mortality was absent. Complications related to endoscopy, balloon placement and removal were absent. Mean time of BIB positioning was 1572 min, range 10-20 min. After the first 3 months of the study, in Group A patients the mean BMI significantly (Po0.001) lowered from 43.571.1 to 38.072.6 kg/m 2 , while in Group B patients the decrease was not significant (from 43.671.8 to 43.172.8 kg/m 2 ). The mean %EWL was significantly higher in Group A than in Group B (34.074.8 vs 2.171%; Po0.001). After crossover, at the end of the following 3 months, the BMI lowered from 38.072.6 to 37.173.4 kg/m 2 and from 43.172.8 to 38.873.1 kg/m 2 in Groups A and B, respectively. Conclusions: The results of this study show that treatment of obese patients with BioEnterics Intragastric Balloon is a safe and effective procedure. In association with appropriate diet it is significantly effective in weight reduction when compared to sham procedure plus diet. The BIB s procedure can play a role in weight reduction in morbidly obese patients or in the preoperative treatment of bariatric patients.

show abstract

Section: -15supporting

confidence: 48%

Section: Discussionmentioning

confidence: 99%

BioEnterics® Intragastric Balloon (BIB®): a short-term, double-blind, randomised, controlled, crossover study on weight reduction in morbidly obese patients

et al. 2005

View full text Add to dashboard Cite

show abstract

“…Seve- ral balloon types were tried but early and late results were poor (1,14,15). In the early years, balloon treatment often produced complications (16,17). The most recently introduced BIB uses saline for inflation.…”

Section: Discussionmentioning

confidence: 99%

“…The most recently introduced BIB uses saline for inflation. BIB has a spherical shape and high volume (400-700 ml) (17,18). BIB has been shown to have very low complication rates, despite its extensive clinical use (19)(20)(21).…”

Section: Discussionmentioning

confidence: 99%

Intragastric balloon treatment of obesity must be combined with bariatric surgery: A pilot study in Turkey

Saruç

Böler²,

Karaarslan³

et al. 2010

Turk J Gastroenterol

View full text Add to dashboard Cite

show abstract

“…Meshkinpour et al [18] studied 19 pa tients who were 25-111 % above their IBW. The patients were studied for 24 weeks con sisting of two separate 12-week periods.…”

Section: Review O F Present Studiesmentioning

confidence: 99%

Use and Misuse of Intragastric Balloons in the Management of Obesity

Kirby

Wade

Mills

1989

Dig Dis

View full text Add to dashboard Cite

Effect of Gastric Bubble as a Weight Reduction Device: A Controlled, Crossover Study

Cited by 72 publications

References 4 publications

BioEnterics® Intragastric Balloon (BIB®): a short-term, double-blind, randomised, controlled, crossover study on weight reduction in morbidly obese patients

BioEnterics® Intragastric Balloon (BIB®): a short-term, double-blind, randomised, controlled, crossover study on weight reduction in morbidly obese patients

Intragastric balloon treatment of obesity must be combined with bariatric surgery: A pilot study in Turkey

Use and Misuse of Intragastric Balloons in the Management of Obesity

Contact Info

Product

Resources

About